Nguyen Thi Phuong Lan
Research Subjects
Nguyen Thi Phuong Lan has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Kenji Hirayama
School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan
6 shared publications - Nguyen Tien Huy
Institute of Research and Development Duy Tan University Da Nang Vietnam
5 shared publications Mihoko Kikuchi
Department of Immunogenetics; Institute of Tropical Medicine (NEKKEN); Nagasaki University; Sakamoto; Nagasaki; Japan
4 shared publicationsKouichi Morita
Department of Virology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan Global COE program, Nagasaki University, Nagasaki, Japan
3 shared publicationsMichio Yasunami
Department of Immunogenetics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan
3 shared publicationsCao Thi Phi Nga
Center for Preventive Medicine, Vinh Long, Viet Nam
2 shared publications
Latest Publications
- Open Access
- 17 July 2022
- Published by Vietnam Medical Journal, Vietnam Medical Association in Tạp chí Y học Việt Nam
- Vol. 516 (1)
THỰC TRẠNG XỬ LÝ CHẤT THẢI Y TẾ TẠI TRUNG TÂM Y TẾ THÀNH PHỐ THÁI NGUYÊN
Xử lý chất thải y tế là vấn đề cần được quan tâm bởi các nguy cơ rủi ro từ chất thải y tế ảnh hưởng lớn đến môi trường cũng như sức khỏe con người. Mục tiêu: Nghiên cứu được thực hiện với mục tiêu mô tả thực trạng xử lý chất thải y tế tại Trung tâm Y tế thành phố Thái Nguyên. Phương pháp: nghiên cứu mô tả, thiết kế nghiên cứu cắt ngang thực hiện với 06 khoa và 32 trạm y tế thuộc Trung tâm Y tế thành phố Thái Nguyên. Kết quả: cho thấy có 50% các khoa và 25% các trạm y tế xử lý sơ bộ chất thải y tế tại nơi phát sinh; 100% các khoa thực hiện xử lý chất thải y tế nguy hại tại Trung tâm Y tế thành phố Thái Nguyên; 81,3% trạm Y tế xử lý chất thải nguy hại bằng hình thức vận chuyển lên trung tâm Y tế, 40,6% bằng đốt thủ công, 37,5% bằng hình thức chôn, vùi và 25,0% bằng đổ vào hố chung với các loại rác khác. Các tác giả khuyến nghị các khoa, Trạm Y tế thuộc Trung tâm Y tế thành phố Thái Nguyên cần thực hiện đúng cách xử lý chất thải y tế theo quy định.
- 17 July 2022
- Published by Vietnam Medical Journal, Vietnam Medical Association in Tạp chí Y học Việt Nam
- Vol. 516 (1)
Open AccessTHỰC TRẠNG XỬ LÝ CHẤT THẢI Y TẾ TẠI TRUNG TÂM Y TẾ THÀNH PHỐ THÁI NGUYÊN
Xử lý chất thải y tế là vấn đề cần được quan tâm bởi các nguy cơ rủi ro từ chất thải y tế ảnh hưởng lớn đến môi trường cũng như sức khỏe con người. Mục tiêu: Nghiên cứu được thực hiện với mục tiêu mô tả thực trạng xử lý chất thải y tế tại Trung tâm Y tế thành phố Thái Nguyên. Phương pháp: nghiên cứu mô tả, thiết kế nghiên cứu cắt ngang thực hiện với 06 khoa và 32 trạm y tế thuộc Trung tâm Y tế thành phố Thái Nguyên. Kết quả: cho thấy có 50% các khoa và 25% các trạm y tế xử lý sơ bộ chất thải y tế tại nơi phát sinh; 100% các khoa thực hiện xử lý chất thải y tế nguy hại tại Trung tâm Y tế thành phố Thái Nguyên; 81,3% trạm Y tế xử lý chất thải nguy hại bằng hình thức vận chuyển lên trung tâm Y tế, 40,6% bằng đốt thủ công, 37,5% bằng hình thức chôn, vùi và 25,0% bằng đổ vào hố chung với các loại rác khác. Các tác giả khuyến nghị các khoa, Trạm Y tế thuộc Trung tâm Y tế thành phố Thái Nguyên cần thực hiện đúng cách xử lý chất thải y tế theo quy định.
- Open Access
- 2 December 2013
- Published by Springer Nature in Critical Care
- Vol. 17 (6) , R280
Development of clinical decision rules to predict recurrent shock in dengue
Introduction: Mortality from dengue infection is mostly due to shock. Among dengue patients with shock, approximately 30% have recurrent shock that requires a treatment change. Here, we report development of a clinical rule for use during a patient’s first shock episode to predict a recurrent shock episode. Methods: The study was conducted in Center for Preventive Medicine in Vinh Long province and the Children’s Hospital No. 2 in Ho Chi Minh City, Vietnam. We included 444 dengue patients with shock, 126 of whom had recurrent shock (28%). Univariate and multivariate analyses and a preprocessing method were used to evaluate and select 14 clinical and laboratory signs recorded at shock onset. Five variables (admission day, purpura/ecchymosis, ascites/pleural effusion, blood platelet count and pulse pressure) were finally trained and validated by a 10-fold validation strategy with 10 times of repetition, using a logistic regression model. Results: The results showed that shorter admission day (fewer days prior to admission), purpura/ecchymosis, ascites/pleural effusion, low platelet count and narrow pulse pressure were independently associated with recurrent shock. Our logistic prediction model was capable of predicting recurrent shock when compared to the null method (P < 0.05) and was not outperformed by other prediction models. Our final scoring rule provided relatively good accuracy (AUC, 0.73; sensitivity and specificity, 68%). Score points derived from the logistic prediction model revealed identical accuracy with AUCs at 0.73. Using a cutoff value greater than −154.5, our simple scoring rule showed a sensitivity of 68.3% and a specificity of 68.2%. Conclusions: Our simple clinical rule is not to replace clinical judgment, but to help clinicians predict recurrent shock during a patient’s first dengue shock episode.
- 2 December 2013
- Published by Springer Nature in Critical Care
- Vol. 17 (6) , R280
Open AccessDevelopment of clinical decision rules to predict recurrent shock in dengue
Introduction: Mortality from dengue infection is mostly due to shock. Among dengue patients with shock, approximately 30% have recurrent shock that requires a treatment change. Here, we report development of a clinical rule for use during a patient’s first shock episode to predict a recurrent shock episode. Methods: The study was conducted in Center for Preventive Medicine in Vinh Long province and the Children’s Hospital No. 2 in Ho Chi Minh City, Vietnam. We included 444 dengue patients with shock, 126 of whom had recurrent shock (28%). Univariate and multivariate analyses and a preprocessing method were used to evaluate and select 14 clinical and laboratory signs recorded at shock onset. Five variables (admission day, purpura/ecchymosis, ascites/pleural effusion, blood platelet count and pulse pressure) were finally trained and validated by a 10-fold validation strategy with 10 times of repetition, using a logistic regression model. Results: The results showed that shorter admission day (fewer days prior to admission), purpura/ecchymosis, ascites/pleural effusion, low platelet count and narrow pulse pressure were independently associated with recurrent shock. Our logistic prediction model was capable of predicting recurrent shock when compared to the null method (P < 0.05) and was not outperformed by other prediction models. Our final scoring rule provided relatively good accuracy (AUC, 0.73; sensitivity and specificity, 68%). Score points derived from the logistic prediction model revealed identical accuracy with AUCs at 0.73. Using a cutoff value greater than −154.5, our simple scoring rule showed a sensitivity of 68.3% and a specificity of 68.2%. Conclusions: Our simple clinical rule is not to replace clinical judgment, but to help clinicians predict recurrent shock during a patient’s first dengue shock episode.
- Open Access
- 5 October 2012
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 337 (1) , 25-30
Development of a single-tube loop-mediated isothermal amplification assay for detection of four pathogens of bacterial meningitis
Several loop-mediated isothermal amplification (LAMP) assays have been developed to detect common causative pathogens of bacterial meningitis (BM). H
- 5 October 2012
- Published by Oxford University Press (OUP) in FEMS Microbiology Letters
- Vol. 337 (1) , 25-30
Open AccessDevelopment of a single-tube loop-mediated isothermal amplification assay for detection of four pathogens of bacterial meningitis
Several loop-mediated isothermal amplification (LAMP) assays have been developed to detect common causative pathogens of bacterial meningitis (BM). H
- Open Access
- 21 February 2012
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 6 (2) , e1505
Association of Mast Cell-Derived VEGF and Proteases in Dengue Shock Syndrome
Recent in-vitro studies have suggested that mast cells are involved in Dengue virus infection. To clarify the role of mast cells in the development of clinical Dengue fever, we compared the plasma levels of several mast cell-derived mediators (vascular endothelial cell growth factor [VEGF], soluble VEGF receptors [sVEGFRs], tryptase, and chymase) and -related cytokines (IL-4, -9, and -17) between patients with differing severity of Dengue fever and healthy controls. The study was performed at Children's Hospital No. 2, Ho Chi Minh City, and Vinh Long Province Hospital, Vietnam from 2002 to 2005. Study patients included 103 with Dengue fever (DF), Dengue hemorrhagic fever (DHF), and Dengue shock syndrome (DSS), as diagnosed by the World Health Organization criteria. There were 189 healthy subjects, and 19 febrile illness patients of the same Kinh ethnicity. The levels of mast cell-derived mediators and -related cytokines in plasma were measured by ELISA. VEGF and sVEGFR-1 levels were significantly increased in DHF and DSS compared with those of DF and controls, whereas sVEGFR-2 levels were significantly decreased in DHF and DSS. Significant increases in tryptase and chymase levels, which were accompanied by high IL-9 and -17 concentrations, were detected in DHF and DSS patients. By day 4 of admission, VEGF, sVEGFRs, and proteases levels had returned to similar levels as DF and controls. In-vitro VEGF production by mast cells was examined in KU812 and HMC-1 cells, and was found to be highest when the cells were inoculated with Dengue virus and human Dengue virus-immune serum in the presence of IL-9. As mast cells are an important source of VEGF, tryptase, and chymase, our findings suggest that mast cell activation and mast cell-derived mediators participate in the development of DHF. The two proteases, particularly chymase, might serve as good predictive markers of Dengue disease severity. To clarify the involvement of mast cells in the development of severe Dengue diseases, plasma levels of mast cell-derived mediators, namely vascular endothelial cell growth factor (VEGF), tryptase, and chymase, were estimated in Dengue patients and control subjects in Vietnam. The levels of the mediators were significantly increased in Dengue hemorrhagic fever (DHF) and Dengue shock syndrome (DSS) patients compared with those of Dengue fever (DF) and control (febrile illness and healthy subjects) patients, and the soluble form of VEGF receptors (sVEGFR)-1 and -2 levels were significantly changed in the patients with severe disease. After 2–4 days of admission, the mediator levels had returned to similar levels as those of DF and control subjects. Furthermore, the levels of the Th17 cell-derived mast-cell activators IL-9 and -17 were increased in DHF and DSS. In-vitro production of VEGF in human mast cells was significantly enhanced in the presence of IL-9 when these cells were inoculated with Dengue virus in the presence of human Dengue virus-immune serum. As mast cells are an important source of VEGF, and tryptase and chymase are considered to be specific markers for mast cell activation, mast cells and mast cell-derived mediators might participate in the development of DHF/DSS.
- 21 February 2012
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 6 (2) , e1505
Open AccessAssociation of Mast Cell-Derived VEGF and Proteases in Dengue Shock Syndrome
Recent in-vitro studies have suggested that mast cells are involved in Dengue virus infection. To clarify the role of mast cells in the development of clinical Dengue fever, we compared the plasma levels of several mast cell-derived mediators (vascular endothelial cell growth factor [VEGF], soluble VEGF receptors [sVEGFRs], tryptase, and chymase) and -related cytokines (IL-4, -9, and -17) between patients with differing severity of Dengue fever and healthy controls. The study was performed at Children's Hospital No. 2, Ho Chi Minh City, and Vinh Long Province Hospital, Vietnam from 2002 to 2005. Study patients included 103 with Dengue fever (DF), Dengue hemorrhagic fever (DHF), and Dengue shock syndrome (DSS), as diagnosed by the World Health Organization criteria. There were 189 healthy subjects, and 19 febrile illness patients of the same Kinh ethnicity. The levels of mast cell-derived mediators and -related cytokines in plasma were measured by ELISA. VEGF and sVEGFR-1 levels were significantly increased in DHF and DSS compared with those of DF and controls, whereas sVEGFR-2 levels were significantly decreased in DHF and DSS. Significant increases in tryptase and chymase levels, which were accompanied by high IL-9 and -17 concentrations, were detected in DHF and DSS patients. By day 4 of admission, VEGF, sVEGFRs, and proteases levels had returned to similar levels as DF and controls. In-vitro VEGF production by mast cells was examined in KU812 and HMC-1 cells, and was found to be highest when the cells were inoculated with Dengue virus and human Dengue virus-immune serum in the presence of IL-9. As mast cells are an important source of VEGF, tryptase, and chymase, our findings suggest that mast cell activation and mast cell-derived mediators participate in the development of DHF. The two proteases, particularly chymase, might serve as good predictive markers of Dengue disease severity. To clarify the involvement of mast cells in the development of severe Dengue diseases, plasma levels of mast cell-derived mediators, namely vascular endothelial cell growth factor (VEGF), tryptase, and chymase, were estimated in Dengue patients and control subjects in Vietnam. The levels of the mediators were significantly increased in Dengue hemorrhagic fever (DHF) and Dengue shock syndrome (DSS) patients compared with those of Dengue fever (DF) and control (febrile illness and healthy subjects) patients, and the soluble form of VEGF receptors (sVEGFR)-1 and -2 levels were significantly changed in the patients with severe disease. After 2–4 days of admission, the mediator levels had returned to similar levels as those of DF and control subjects. Furthermore, the levels of the Th17 cell-derived mast-cell activators IL-9 and -17 were increased in DHF and DSS. In-vitro production of VEGF in human mast cells was significantly enhanced in the presence of IL-9 when these cells were inoculated with Dengue virus in the presence of human Dengue virus-immune serum. As mast cells are an important source of VEGF, and tryptase and chymase are considered to be specific markers for mast cell activation, mast cells and mast cell-derived mediators might participate in the development of DHF/DSS.
- 1 December 2011
- Published by Elsevier in Parasitology International
- Vol. 60 (4) , 347-356
Association of HLA and post-schistosomal hepatic disorder: A systematic review and meta-analysis
- 1 December 2011
- Published by Elsevier in Parasitology International
- Vol. 60 (4) , 347-356
Association of HLA and post-schistosomal hepatic disorder: A systematic review and meta-analysis
- Open Access
- 7 October 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (10) , e25969
Elevated Levels of Cell-Free Circulating DNA in Patients with Acute Dengue Virus Infection
Apoptosis is thought to play a role in the pathogenesis of severe dengue and the release of cell-free DNA into the circulatory system in several medical conditions. Therefore, we investigated circulating DNA as a potential biomarker for severe dengue. A direct fluorometric degradation assay using PicoGreen was performed to quantify cell-free DNA from patient plasma. Circulating DNA levels were significantly higher in patients with dengue virus infection than with other febrile illnesses and healthy controls. Remarkably, the increase of DNA levels correlated with the severity of dengue. Additionally, multivariate logistic regression analysis showed that circulating DNA levels independently correlated with dengue shock syndrome. Circulating DNA levels were increased in dengue patients and correlated with dengue severity. Additional studies are required to show the benefits of this biomarker in early dengue diagnosis and for the prognosis of shock complication.
- 7 October 2011
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (10) , e25969
Open AccessElevated Levels of Cell-Free Circulating DNA in Patients with Acute Dengue Virus Infection
Apoptosis is thought to play a role in the pathogenesis of severe dengue and the release of cell-free DNA into the circulatory system in several medical conditions. Therefore, we investigated circulating DNA as a potential biomarker for severe dengue. A direct fluorometric degradation assay using PicoGreen was performed to quantify cell-free DNA from patient plasma. Circulating DNA levels were significantly higher in patients with dengue virus infection than with other febrile illnesses and healthy controls. Remarkably, the increase of DNA levels correlated with the severity of dengue. Additionally, multivariate logistic regression analysis showed that circulating DNA levels independently correlated with dengue shock syndrome. Circulating DNA levels were increased in dengue patients and correlated with dengue severity. Additional studies are required to show the benefits of this biomarker in early dengue diagnosis and for the prognosis of shock complication.
- Open Access
- 1 January 2011
- Published by Japanese Society of Tropical Medicine in Tropical Medicine and Health
- Vol. 39 (4SUPPLEMEN) , S73-S81
Host genetic susceptibility to severe dengue infection
Epidemiological evidence indicates that host genetic factors are relevant and predispose DHF/DSS development. Here, we review the host genetic studies concerning human leucocyte antigens, antibody receptors, immune/inflammatory mediators, attachment molecules, cytokines and other factors exerting an immunoregulatory effect as well as the current genome-wide association studies. We also discuss some viewpoints on future challenges related to the design of safe and effective prevention and treatment options.
- 1 January 2011
- Published by Japanese Society of Tropical Medicine in Tropical Medicine and Health
- Vol. 39 (4SUPPLEMEN) , S73-S81
Open AccessHost genetic susceptibility to severe dengue infection
Epidemiological evidence indicates that host genetic factors are relevant and predispose DHF/DSS development. Here, we review the host genetic studies concerning human leucocyte antigens, antibody receptors, immune/inflammatory mediators, attachment molecules, cytokines and other factors exerting an immunoregulatory effect as well as the current genome-wide association studies. We also discuss some viewpoints on future challenges related to the design of safe and effective prevention and treatment options.
- Open Access
- 18 April 2007
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 2 (4) , e361
Dipstick for Rapid Diagnosis of Shigella flexneri 2a in Stool
Shigellosis or bacillary dysentery, an acute bloody diarrhoea, is a major public health burden in developing countries. In the absence of prompt and appropriate treatment, the infection is often fatal, particularly in young malnourished children. Here, we describe a new diagnostic test for rapid detection, in stool, at the bedside of patients, of Shigella flexneri 2a, the most predominant agent of the endemic form of the disease. The test is based on the detection of S.flexneri 2a lipopolysaccharide (LPS) using serotype 2a-specific monoclonal antibodies coupled to gold particles and displayed on one-step immunochromatographic dipstick. A concentration as low as 20 ng/ml of LPS is detected in distilled water and in reconstituted stools in under 15 minutes. The threshold of detection corresponds to a concentration of 5×107 CFU/ml of S. flexneri 2a, which provides an unequivocal positive reaction in three minutes in distilled water and reconstituted stools. The specificity is 100% when tested with a battery of Shigella and unrelated strains, in culture. When tested in Vietnam, on clinical samples, the specificity and sensitivity were 99.2 and 91.5%, respectively. A decrease of the sensitivity during the evaluation on stool samples was observed after five weeks at room temperature and was due to moistening of the dipsticks caused by the humidity of the air during the fifth week of the evaluation. This drawback is now overcome by improving the packaging and providing dipsticks individually wrapped in waterproof bags. This simple dipstick-bases test represents a powerful tool for case management and epidemiological surveys.
- 18 April 2007
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 2 (4) , e361
Open AccessDipstick for Rapid Diagnosis of Shigella flexneri 2a in Stool
Shigellosis or bacillary dysentery, an acute bloody diarrhoea, is a major public health burden in developing countries. In the absence of prompt and appropriate treatment, the infection is often fatal, particularly in young malnourished children. Here, we describe a new diagnostic test for rapid detection, in stool, at the bedside of patients, of Shigella flexneri 2a, the most predominant agent of the endemic form of the disease. The test is based on the detection of S.flexneri 2a lipopolysaccharide (LPS) using serotype 2a-specific monoclonal antibodies coupled to gold particles and displayed on one-step immunochromatographic dipstick. A concentration as low as 20 ng/ml of LPS is detected in distilled water and in reconstituted stools in under 15 minutes. The threshold of detection corresponds to a concentration of 5×107 CFU/ml of S. flexneri 2a, which provides an unequivocal positive reaction in three minutes in distilled water and reconstituted stools. The specificity is 100% when tested with a battery of Shigella and unrelated strains, in culture. When tested in Vietnam, on clinical samples, the specificity and sensitivity were 99.2 and 91.5%, respectively. A decrease of the sensitivity during the evaluation on stool samples was observed after five weeks at room temperature and was due to moistening of the dipsticks caused by the humidity of the air during the fifth week of the evaluation. This drawback is now overcome by improving the packaging and providing dipsticks individually wrapped in waterproof bags. This simple dipstick-bases test represents a powerful tool for case management and epidemiological surveys.